pembrolizumab,lenvatinib
eisai,merck
['gi ', 'hcc', '#gi', 'leap-002', 'pembro', 'lenva']
was it a leap of faith?? final results from leap-002 with lenva/pembro in #hcc. negative study - os at 21.2 mths with higher than expected os for lenva alone. kicking off the #gi session 
GI Oncologist, focus pancreatic, biliary cancers, personalized tx’s. Love to dance, travel, and spend time with my family. ASCO FCOI: https://t.co/oXHqwAT6p6